Erythropoietin Concentration in Boys With p.His63Asp Polymorphism of the HFE Gene
- 22 February 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 44 (1) , e68-e73
Abstract
The molecular mechanism that regulates iron homeostasis is based on a network of signals, which reflect on the iron requirements of the body. HFE-related hemochromatosis is characterized by excessive intestinal absorption of dietary iron, in particular cases resulting in pathologically high iron storage in tissues and organs. During childhood, HFE gene homozygosity or heterozygosity manifests exclusively in the form of biochemical abnormalities. Because of their mutual link, bioavailable iron and endogenous erythropoietin (EPO) are indispensable for effective erythropoiesis. We analyzed the impact of p.(His63Asp) polymorphism of the HFE gene on erythropoiesis taking into consideration endogenous EPO production in the developmental age. In the study we performed, we observed a significant, strong and negative correlation between the concentration of EPO, hemoglobin, and red blood cell count. A negative trend was also noted on the impact of iron concentration and transferrin saturation on EPO production. In conclusion, this preliminary study demonstrates an impaired impact of endogenous EPO on erythropoiesis in the presence of increased iron content in carriers of p.(His63Asp) (heterozygotes) variant of the HFE gene in developmental age.Keywords
This publication has 18 references indexed in Scilit:
- HaemochromatosisThe Lancet, 2016
- The mutual control of iron and erythropoiesisInternational Journal of Laboratory Hematology, 2016
- Hepcidin: regulation of the master iron regulatorBioscience Reports, 2015
- Natural history of HFE simple heterozygosity for C282Y and H63D: A prospective 12‐year studyJournal of Gastroenterology and Hepatology, 2014
- Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemiaCancer, 2013
- Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in miceInternational Journal of Hematology, 2012
- Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidinHaematologica, 2009
- The erythropoietin receptor in normal and cancer tissuesCritical Reviews in Oncology/Hematology, 2008
- Iron storage disease: Facts, fiction and progressBlood Cells, Molecules, and Diseases, 2007
- Geography of HFE C282Y and H63D MutationsGenetic Testing, 2000